We also found greatly increased levels of CD4+CD8+ T -cells in the tumor (+ 1.7%, p < 0.005), lungs (+ 0.07%, p < 0.05), and blood (+ 2%, p < 0.005) of DC-iMB treated animals compared to marginal levels of both T-cell types in the other groups. The gene discussed is CD4; the disease is neoplasm.